Kratom, a tree native to Southeast Asia, has gained significant popularity in the United States over the past decade as an over-the-counter supplement available in pill, powder, and liquid forms. The herb entered the US market around 2016 and is now widely sold through convenience stores, petrol stations, vape shops, and other retail outlets. Despite growing demand, kratom remains unregulated by the US Food and Drug Administration, creating what health experts describe as a major public health concern.
The plant’s compounds, including 7-Hydroxymitragynine, interact with hormones such as dopamine, producing effects ranging from mild stimulation at lower doses—comparable to caffeine—to euphoria and hallucinations at higher doses. Users have sought out kratom for pain management, anxiety relief, and as a potential aid in addressing opioid addiction. However, medical professionals warn that the lack of federal oversight means consumers cannot verify what they are actually consuming, as products may be manufactured without quality controls or ingredient verification.
Health risks associated with kratom use include central nervous system depression, which can result in cardiovascular collapse and respiratory failure. Users may also develop tolerance, addiction, and withdrawal symptoms. Some individuals have reported taking up to 20 pills daily to achieve desired effects. Mental health professionals have documented cases where kratom dependency has damaged relationships, caused job loss, and resulted in substantial financial expenditure.
Currently, kratom is banned in 11 states, with Massachusetts being the most recent to implement a temporary emergency order in August. The US Drug Enforcement Agency previously attempted to classify kratom as Schedule 1 but withdrew the effort after receiving public opposition. Internationally, kratom is illegal in countries including the UK and Malaysia, where the plant originates. In the US, pro-kratom organizations are advocating for regulations targeting synthetic products while opposing broader bans, while opponents continue calling for stricter state-level restrictions.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI